Decreased expression of IL-17 pathway genes in blood in patients with plaque psoriasis treated with the anti-IL-17A monoclonal antibody, ixekizumab

被引：0
|
作者：
Krueger, J. G. [1 ]
Dow, E. R. [2 ]
Nantz, E. [2 ]
Komocsar, W. J. [2 ]
Banerjee, P. [2 ]
Leonardi, C. [3 ]
Cameron, G. S. [2 ]
Banerjee, S. [2 ]
Hoffman, R. W. [2 ]
机构：
[1] Rockefeller Univ, New York, NY 10021 USA
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
[3] St Louis Univ, Sch Med, St Louis, MO USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2013年 / 133卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
104
引用
收藏
页码：S18 / S18
页数：1
相关论文
共 50 条
  • [41] Monoclonal Antibody Y11 Anti-Rat IL-17 Protein
    Zhang, Hongwei
    HYBRIDOMA, 2011, 30 (03): : 322 - 322
  • [42] In-depth characterization of the expression of IL-17 isoforms in psoriasis
    Senra, L.
    Stalder, R.
    Boehncke, W.
    Brembilla, N. C.
    EXPERIMENTAL DERMATOLOGY, 2016, 25 (03) : E7 - E7
  • [43] IL-17 EXPRESSION IN SKIN OF LEPROSY PATIENTS
    De Paula, L.
    Malheiro, A.
    Cardoso, C. R.
    Cunha, M. G. S.
    da Silva, J. S.
    Silva, G. A. V.
    dos Santos, M. P.
    Passos, I. M.
    INFLAMMATION RESEARCH, 2011, 60 : 111 - 111
  • [44] Interleukin (IL)-19 is a novel component of the pathogenetic IL-23/IL-17 pathway in psoriasis
    Witte, E.
    Kokolakis, G.
    Witte, K.
    Philipp, S.
    Babel, N.
    Wittig, B. M.
    Erdmann-Keding, M.
    Kadin, M. E.
    Volk, H. -D.
    Sterry, W.
    Wolk, K.
    Sabat, R.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (06) : E155 - E155
  • [45] Management of Moderate to Severe Plaque Psoriasis: The Emerging Role of IL-17 Inhibition
    Bissonnette, Robert
    Bourcier, Marc
    Gooderham, Melinda
    Hong, Chih-ho
    Landells, Ian
    Lynde, Charles
    Papp, Kim
    Poulin, Yves
    Vender, Ronald
    Wiseman, Marni C.
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2017, 21 : 2S - 40S
  • [46] IL-17 Monoclonal Antibody Related HPV Exacerbation: A Case Report
    Kucukhemek, Fahrettin
    Aypek, Yagmur
    Ogut, Betul
    Adisen, Esra
    INDIAN JOURNAL OF DERMATOLOGY, 2024, 69 (06)
  • [47] The impact of biologics targeting the IL-17 and IL-23 pathways on metabolic indicators in plaque psoriasis
    Jiang, Wenzhuo
    Li, Qiujv
    Zheng, Wenjun
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2025, 317 (01)
  • [48] Targeting the IL-23/IL-17 Pathway in Psoriasis: the Search for the Good, the Bad and the Ugly
    Sofie Mylle
    Lynda Grine
    Reinhart Speeckaert
    Jo L.W. Lambert
    Nanja van Geel
    American Journal of Clinical Dermatology, 2018, 19 : 625 - 637
  • [49] Targeting the IL-23/IL-17 Pathway in Psoriasis: the Search for the Good, the Bad and the Ugly
    Mylle, Sofie
    Grine, Lynda
    Speeckaert, Reinhart
    Lambert, Jo L. W.
    van Geel, Nanja
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2018, 19 (05) : 625 - 637
  • [50] Brodalumab: the first anti- IL-17 receptor agent for psoriasis
    Puig, L.
    DRUGS OF TODAY, 2017, 53 (05) : 283 - 297
12345